Morgan Stanley’s HANSEN MEDICAL, INC. COM NEW HNSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-5,275
| Closed | -$21K | – | 6737 |
|
|
2016
Q2 | $21K | Sell |
5,275
-150
| -3% | -$572 | ﹤0.01% | 5844 |
|
|
2016
Q1 | $14K | Buy |
5,425
+1,064
| +24% | +$2.54K | ﹤0.01% | 6042 |
|
|
2015
Q4 | $10K | Buy |
4,361
+150
| +4% | +$490 | ﹤0.01% | 6255 |
|
|
2015
Q3 | $15K | Sell |
4,211
-1,082
| -20% | -$7.07K | ﹤0.01% | 6143 |
|
|
2015
Q2 | $48K | Buy |
5,293
+493
| +10% | +$4.5K | ﹤0.01% | 5869 |
|
|
2015
Q1 | $42K | Buy |
4,800
+280
| +6% | +$2.28K | ﹤0.01% | 5862 |
|
|
2014
Q4 | $25K | Sell |
4,520
-7,195
| -61% | -$59.6K | ﹤0.01% | 5999 |
|
|
2014
Q3 | $138K | Sell |
11,715
-1,405
| -11% | -$17K | ﹤0.01% | 5331 |
|
|
2014
Q2 | $172K | Sell |
13,120
-34,085
| -72% | -$592K | ﹤0.01% | 5241 |
|
|
2014
Q1 | $1.23M | Buy |
47,205
+38,630
| +450% | +$866K | ﹤0.01% | 3828 |
|
|
2013
Q4 | $148K | Sell |
8,575
-1,890
| -18% | -$35K | ﹤0.01% | 5171 |
|
|
2013
Q3 | $187K | Sell |
10,465
-5,050
| -33% | -$79.4K | ﹤0.01% | 4918 |
|
|
2013
Q2 | $223K | Buy |
+15,515
| New | +$275K | ﹤0.01% | 4780 |
|
Morgan Stanley's HNSN Position: Q3 2016 in Review
Morgan Stanley sold out of HANSEN MEDICAL, INC. COM NEW (HNSN) in Q3 2016, closing a stake of 5,275 shares — an estimated $21K sold.
Morgan Stanley first reported a position in HNSN in Q2 2013 and held it in 13 quarters. The position peaked at $1.23M in Q1 2014. 0 funds tracked by Wall St. Rank hold HNSN as of Q3 2016.
- Morgan Stanley reported no remaining HANSEN MEDICAL, INC. COM NEW position as of Q3 2016 after selling out during the quarter.
- Morgan Stanley sold 5,275 HANSEN MEDICAL, INC. COM NEW shares in Q3 2016, an estimated $21K.
- Morgan Stanley first reported a position in HANSEN MEDICAL, INC. COM NEW in Q2 2013 and held it in 13 quarters.
- Morgan Stanley's HANSEN MEDICAL, INC. COM NEW position peaked at $1.23M in Q1 2014.
- 0 funds tracked by Wall St. Rank held HANSEN MEDICAL, INC. COM NEW as of Q3 2016.
Based on Morgan Stanley's 13F filing for Q3 2016, filed 10 Nov 2016.